The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
The DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
A cellular phosphoprotein with an apparent molecular mass of 90 kd (p90) that forms a complex with both mutant and wild-type p53 protein has been characterized, purified, and identified. The protein was identified as a product of the murine double minute 2 gene (mdm-2). The mdm-2 gene enhances the tumorigenic potential of cells when it is overexpressed and encodes a putative transcription factor. To determine if mdm-2 could modulate p53 transactivation, a p53-responsive element from the muscle creatine kinase gene was employed. A wild-type p53-expressing plasmid enhanced the expression of the p53-responsive element when cotransfected into cells that contain no endogenous p53. When a cosmid expressing mdm-2 was transfected with this p53-expressing plasmid, the transactivation of the p53-responsive element was inhibited. Thus, a product of the mdm-2 oncogene forms a tight complex with the p53 protein, and the mdm-2 oncogene can inhibit p53-mediated transactivation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Western blot analyses of frozen tumor extracts showed increased Mdm2 levels in tumors that had greatly attenuated p21 induction in response to DNA damage (data not shown), suggesting that the p53dependent DNA damage checkpoint is compromised by overexpression of Mdm2, the major inhibitor of p53 (40, 41).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [41]
In the citing paper
“Western blot analyses of frozen tumor extracts showed increased Mdm2 levels in tumors that had greatly attenuated p21 induction in response to DNA damage (data not shown), suggesting that the p53dependent DNA damage checkpoint is compromised by overexpression of Mdm2, the major inhibitor of p53 (40, 41).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [41]
In the citing paper
“Although both MDM2 and MDMX can inhibit p53 transactivation function by engaging its amino-terminal transactivation domain via related N-terminal hydrophobic pockets2,11,12”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [2]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Self-citationAssociation of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Self-citationT antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Self-citationHow eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Self-citation
Research works printed but not linked: 1
- Hinds, 1990, Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells, Cell Growth Diff., 1, 571
Cited by
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
“Interference with normal p53 function by viral proteins or even by abnormal binding of ~53 protein to endogenous cellular proteins (Momand et al., 1992; Oliner at al., 1992) could also lead to the same abnormal response to DNA damage and contribute to tumor cell development.”
Background
Metadata
- Authors
- Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J.
- Affiliations
- Princeton University (US)
- University of Pennsylvania (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-06
- Volume
- 69
- Issue
- 7
- Pages
- 1237-1245
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2099907467
- Cited by
- 3,113
- References
- 55
- Citations by year
- 2026: 31 · 2025: 36 · 2024: 46 · 2023: 60 · 2022: 58 · 2021: 65 · 2020: 88 · 2019: 60 · 2018: 65 · 2017: 71 · 2016: 75 · 2015: 83 · 2014: 118 · 2013: 90 · 2012: 102
- FWCI
- 60.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5f32ca008771-02, 5f31ca009258-03)
- National Cancer Institute (CA09258-07, 5 F32 CA08771)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- MDM2, p53, p53 transactivation, p53 response elements, transcriptional repression, oncogenes, protein complex formation, tumorigenicity, transcription factors
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Molecular Sequence Data, Molecular Weight, Neoplasm Proteins, Nuclear Proteins, Plasmids, Protein Binding, Proto-Oncogene Proteins, Sequence Homology, Nucleic Acid, Oncogene Proteins, Transcriptional Activation, Tumor Suppressor Protein p53, Mice, Rats, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. https://app.cochat.ai/papers/10.1016/0092-8674(92)90644-r
- The paper
- Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. https://doi.org/10.1016/0092-8674(92)90644-r
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.